Researchers here have linked an increase in two immune system proteins essential for inflammation to a latent viral infection and proposed a chain of events that might accelerate cardiovascular disease. The same process may be involved in a host of other ailments plaguing the elderly.
Bristol researchers have identified a heart protection mechanism in mice that surgeons and cardiologists may be able to exploit to improve treatments for patients in future.
Over the past three decades, the rising obesity epidemic has been accompanied by a proliferation of weight-loss plans. However, as a new study by researchers from the University of Massachusetts Medical School (UMMS) reveals, these weight-loss plans vary significantly in their ability to positively affect heart health.
Khun-Phra is a health product promoted to treat arthritis and joint pain. Health Canada is advising consumers not to use the product due to concerns about possible side-effects.
Bristol researchers have identified a heart protection mechanism in mice that surgeons and cardiologists may be able to exploit to improve treatments for patients in future.
A new type of non-invasive imaging test may help prevent heart attacks. Known as Low-Dose Coronary CT Angiogram (CTA), the test uses less radiation than conventional imaging tests and may help detect heart disease certain asymptomatic patients.
Most clinical trials for new diabetes drugs do not consider the impact medication will have on a patient’s quality of life or other outcomes that are important to patients, such as the risk of developing complications associated with diabetes, according to a Mayo Clinic commentary in the current issue of The Lancet.
It can be called a chain reaction. People who are overweight are more likely to develop heart disease, and the heart disease sufferers are almost twice as likely to develop bowel cancer.
Over 40000 people of Nepal are suffering from heart diseases, according to a latest report published by the Nepal Heart Foundation (NHF). Heart diseases account for 25 per cent of the total deaths in the country, the report said.
Temporarily diverting blood leaving the liver during chemotherapy could prolong the lives of people with primary or secondary liver tumours. The hour-long procedure allows massive doses of chemotherapy drugs to reach the liver and kill the cancer cells without poisoning the rest of the body.